SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Aquestive Therapeutics, Inc. (Beta Bionics) due to significant stock losses and possible misleading statements made by the company [2][5]. Group 1: Company Overview - Aquestive Therapeutics, Inc. is also referred to as Beta Bionics and is listed on NASDAQ under the ticker BBNX [2]. - The company has experienced a significant decline in its stock price, with shares plunging approximately 37% on January 9, 2026, following an announcement regarding fewer patient starts than analysts had estimated for the fourth quarter [5]. Group 2: Legal Investigation - The investigation by Faruqi & Faruqi focuses on whether Beta Bionics issued misleading statements or failed to disclose important information that could affect investors [5]. - Investors who have suffered significant losses in Beta Bionics stock or options are encouraged to contact the law firm to discuss their legal rights [1].